Shares of Theralase Technologies Inc. (CVE:TLT – Get Free Report) fell 4.6% during mid-day trading on Friday . The company traded as low as C$0.30 and last traded at C$0.31. 300,320 shares traded hands during mid-day trading, an increase of 10% from the average session volume of 272,498 shares. The stock had previously closed at C$0.33.
Theralase Technologies Trading Down 4.6%
The company has a 50 day simple moving average of C$0.21 and a two-hundred day simple moving average of C$0.20. The company has a debt-to-equity ratio of 14.85, a quick ratio of 3.40 and a current ratio of 1.91. The firm has a market cap of C$82.12 million, a PE ratio of -17.22 and a beta of -0.13.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Articles
- Five stocks we like better than Theralase Technologies
- Trade this between 9:30 and 10:45 am EST
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- The buying spree that no one is talking about
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
